INTERACTIVE
WEBINAR

 
Call-in teleconferencing
 
Video demonstrations included in the presentation
 
 
 
610-399-4897
 


 

 

 
 

 
 
RISK-BASED APPROACH TO GMP COMPLIANCE
Understanding FDA and ICH Guidances  and the ASTM Standard approach to Risk based GMP compliance.

September 22, 2009 WEBINAR
NOON - 1:30 pm EDT
 
 This Webinar will review the background and guidance dealing with science and risk based GMP compliance and the various approaches suggested by FDA, ICH, and ASTM to mitigate risk and ensure proper compliance is achieved. The documents that will be reviewed include:

  • FDA Guidance “Pharmaceutical CGMP for the 21st century – A Risk-based Approach” and its implication. 
Additionally subsequent progress reports issued by the FDA regarding suggested approaches to mitigate risk will be discussed
  • Review ICH Q8, Q9, Q10, and ASTM Standard E2500
  • How does QbD fit within the big picture - ICH Q8 (R1)
  • What is meant by Product Life Cycle and Manufacturing    Life Cycle
  • The jargon and acronym definitions

We will discuss the knowledge, design and control space concepts and their role in mitigating risk and the concept of continuous improvement and how to achieve it.


Instructor: Gamal Amer, Ph. D.
 
Dr. Amer is Principal at Premier Compliance Services, Inc.; Management Consultants for compliance and manufacturing operations performance in the life sciences industry. He holds a Ph. D. in Chemical Engineering and has over 30 years of experience in the Pharmaceutical and related industries. He has held positions of increased responsibility with leading pharmaceutical, consumer product and engineering consulting firms over the years. His experience includes comprehensive process design in bulk pharmaceutical manufacturing, biotechnology manufacturing, pharmaceutical solid dosage manufacturing and containment of potent and radioactive therapeutics. He is also experienced with facility development for therapeutic products operations. Dr. Amer is a recognized expert in GMP compliance and validation. He has consulted for many of the leading pharmaceutical, biotechnology and medical device manufacturers. He has lectured extensively in the US, Europe, Asia and the Middle East, tau ght many courses, and authored many papers which were published in peer reviewed publication. He is a member of ISPE, PDA, ACS and AIChE.
 
 FEE: $345 for one person.
Call for special discounts for multiple participants from your company.
 
610-399-4897
 
ECCWEB129